Suzhou Porton Advanced Solutions Ltd. entered into a strategic partnership with Bennu Biotherapeutics to advance cell and gene therapy R&D pipelines. The partnership aims to accelerate the development of T-cell therapies for tumors and autoimmune diseases.
Porton Biologics Announces Closing Series-A Financing To Drive Commercial Production Of Gene And Cell Therapy